# Anti-VEGF Instead of Intraoperative PRP in Proliferative Diabetic Retinopathy

> **NCT03633266** · NA · UNKNOWN · sponsor: **Wenzhou Medical University** · enrollment: 220 (estimated)

## Conditions studied

- Anti-VEGF
- Proliferative Diabetic Retinopathy
- PRP
- Vitrectomy

## Interventions

- **PROCEDURE:** anti-VEGF
- **PROCEDURE:** PRP

## Key facts

- **NCT ID:** NCT03633266
- **Lead sponsor:** Wenzhou Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-09-01
- **Primary completion:** 2020-12-01
- **Final completion:** 2022-12-01
- **Target enrollment:** 220 (ESTIMATED)
- **Last updated:** 2018-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03633266

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03633266, "Anti-VEGF Instead of Intraoperative PRP in Proliferative Diabetic Retinopathy". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03633266. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*